News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
788,640 Results
Type
Article (64911)
Company Profile (685)
Press Release (723043)
Multimedia
Podcasts (114)
Webinars (14)
Section
Business (221144)
Career Advice (2933)
Deals (37713)
Drug Delivery (118)
Drug Development (86853)
Employer Resources (181)
FDA (17506)
Job Trends (16617)
News (374442)
Policy (36268)
Tag
Academia (2951)
Accelerated approval (10)
Adcomms (26)
Allergies (105)
Alliances (53879)
ALS (117)
Alzheimer's disease (1541)
Antibody-drug conjugate (ADC) (174)
Approvals (17477)
Artificial intelligence (344)
Autoimmune disease (32)
Automation (18)
Bankruptcy (383)
Best Places to Work (12586)
BIOSECURE Act (22)
Biosimilars (131)
Biotechnology (471)
Bladder cancer (99)
Brain cancer (37)
Breast cancer (384)
Cancer (3017)
Cardiovascular disease (235)
Career advice (2454)
Career pathing (33)
CAR-T (203)
CDC (40)
Cell therapy (543)
Cervical cancer (24)
Clinical research (71060)
Collaboration (1094)
Company closure (3)
Compensation (710)
Complete response letters (28)
COVID-19 (2829)
CRISPR (65)
C-suite (348)
Cystic fibrosis (120)
Data (3073)
Decentralized trials (2)
Denatured (26)
Depression (71)
Diabetes (367)
Diagnostics (6898)
Digital health (24)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (149)
Drug pricing (142)
Drug shortages (33)
Duchenne muscular dystrophy (128)
Earnings (92700)
Editorial (48)
Employer branding (22)
Employer resources (156)
Events (125954)
Executive appointments (909)
FDA (19226)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (993)
Gene editing (142)
Generative AI (28)
Gene therapy (413)
GLP-1 (888)
Government (5011)
Grass and pollen (6)
Guidances (181)
Healthcare (20746)
HIV (43)
Huntington's disease (31)
IgA nephropathy (41)
Immunology and inflammation (172)
Immuno-oncology (9)
Indications (40)
Infectious disease (3022)
Inflammatory bowel disease (160)
Inflation Reduction Act (12)
Influenza (70)
Intellectual property (123)
Interviews (509)
IPO (17453)
IRA (54)
Job creations (4496)
Job search strategy (2084)
Kidney cancer (14)
Labor market (53)
Layoffs (563)
Leadership (24)
Legal (8861)
Liver cancer (84)
Longevity (12)
Lung cancer (420)
Lymphoma (211)
Machine learning (11)
Management (63)
Manufacturing (416)
MASH (96)
Medical device (14571)
Medtech (14576)
Mergers & acquisitions (20989)
Metabolic disorders (925)
Multiple sclerosis (102)
NASH (22)
Neurodegenerative disease (131)
Neuropsychiatric disorders (37)
Neuroscience (2273)
NextGen: Class of 2025 (7506)
Non-profit (5065)
Now hiring (48)
Obesity (473)
Opinion (283)
Ovarian cancer (104)
Pain (119)
Pancreatic cancer (125)
Parkinson's disease (198)
Partnered (23)
Patents (314)
Patient recruitment (170)
Peanut (55)
People (62923)
Pharmaceutical (139)
Pharmacy benefit managers (25)
Phase I (22109)
Phase II (31023)
Phase III (23311)
Pipeline (1678)
Policy (234)
Postmarket research (3031)
Preclinical (9716)
Press Release (72)
Prostate cancer (147)
Psychedelics (41)
Radiopharmaceuticals (277)
Rare diseases (508)
Real estate (6922)
Recruiting (69)
Regulatory (25073)
Reports (51)
Research institute (2632)
Resumes & cover letters (469)
Rett syndrome (10)
RNA editing (9)
RSV (55)
Schizophrenia (96)
Series A (167)
Series B (117)
Service/supplier (28)
Sickle cell disease (65)
Special edition (22)
Spinal muscular atrophy (161)
Sponsored (33)
Startups (4032)
State (2)
Stomach cancer (15)
Supply chain (82)
Tariffs (63)
The Weekly (86)
Vaccines (862)
Venture capital (55)
Weight loss (305)
Women's health (47)
Worklife (18)
Date
Today (69)
Last 7 days (391)
Last 30 days (1966)
Last 365 days (33108)
2025 (17769)
2024 (37583)
2023 (42331)
2022 (53728)
2021 (58532)
2020 (57492)
2019 (50963)
2018 (38640)
2017 (35113)
2016 (35216)
2015 (41391)
2014 (36413)
2013 (33538)
2012 (33479)
2011 (33922)
2010 (32826)
Location
Africa (965)
Alabama (69)
Alaska (7)
Arizona (266)
Arkansas (14)
Asia (44663)
Australia (7820)
California (7758)
Canada (2408)
China (717)
Colorado (337)
Connecticut (348)
Delaware (204)
Europe (102491)
Florida (1154)
Georgia (262)
Hawaii (2)
Idaho (64)
Illinois (709)
India (30)
Indiana (384)
Iowa (18)
Japan (236)
Kansas (114)
Kentucky (33)
Louisiana (18)
Maine (73)
Maryland (1096)
Massachusetts (5925)
Michigan (271)
Minnesota (482)
Mississippi (3)
Missouri (100)
Montana (32)
Nebraska (26)
Nevada (82)
New Hampshire (72)
New Jersey (2176)
New Mexico (30)
New York (2178)
North Carolina (1242)
North Dakota (10)
Northern California (3350)
Ohio (251)
Oklahoma (17)
Oregon (48)
Pennsylvania (1655)
Puerto Rico (18)
Rhode Island (39)
South America (1357)
South Carolina (36)
South Dakota (1)
Southern California (2879)
Tennessee (129)
Texas (1184)
United States (29228)
Utah (230)
Virginia (210)
Washington D.C. (79)
Washington State (686)
West Virginia (4)
Wisconsin (86)
788,640 Results for "new england biolabs inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
New England Biolabs® and Inorevia to partner on novel solutions for the preparation of challenging samples for next generation sequencing
New England Biolabs (NEB ®) and Inorevia announce a collaboration to develop automated workflows to maximize data quality by preparation of sequence-ready libraries from challenging samples using NEBNext® library preparation reagents on Inorevia’s Magelia® automation platform.
June 18, 2024
·
4 min read
Press Releases
Keymed Biosciences Announces the Latest Clinical Trial Results of CM336 Published in the New England Journal of Medicine
June 13, 2025
·
2 min read
New England Biolabs® Launches NEBNext® Enzymatic 5hmC-seq Kit, for enzyme-based 5hmC detection at single-base resolution
New England Biolabs (NEB®) today announced the launch of the NEBNext Enzymatic 5hmC-seq Kit (E5hmC-seq™), a novel enzyme-based method for the specific detection of 5hmC sites.
February 13, 2024
·
2 min read
Press Releases
Akero Therapeutics Announces Publication of Phase 2b SYMMETRY Trial in the New England Journal of Medicine
May 12, 2025
·
7 min read
Press Releases
Phase 3 Clinical Study of Mazdutide in Chinese Adults with Overweight or Obesity (GLORY-1) Published in The New England Journal of Medicine (NEJM)
May 26, 2025
·
13 min read
Press Releases
Lilly’s oral GLP-1, orforglipron, showed compelling efficacy and a safety profile consistent with injectable GLP-1 medicines, in complete Phase 3 results published in The New England Journal of Medicine
June 23, 2025
·
11 min read
biomodal Files Patent Infringement Lawsuit Against New England Biolabs
July 2, 2024
·
2 min read
Press Releases
Novo Nordisk A/S: CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults with overweight or obesity in REDEFINE 1, published in New England Journal of Medicine
June 23, 2025
·
8 min read
Press Releases
Revvity Expands Alliance with Genomics England to Drive Research into Newborn Genomic Sequencing in England
March 21, 2025
·
3 min read
Press Releases
RetinalGenix Technologies, Inc. Announces Laboratory Lease Agreement with Life Science Incubator MBC BioLabs
May 5, 2025
·
5 min read
1 of 78,864
Next
